MetLife Investment Management, LLC - INSMED INC ownership

INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 204 filers reported holding INSMED INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of INSMED INC
ValueSharesWeighting
Q3 2023$1,740,180
+19.7%
68,9180.0%0.01%
+27.3%
Q2 2023$1,454,170
+20.4%
68,918
-2.7%
0.01%
+22.2%
Q1 2023$1,207,805
-14.7%
70,8390.0%0.01%
-18.2%
Q4 2022$1,415,363
+4.5%
70,839
+12.7%
0.01%
-8.3%
Q3 2022$1,354,521
+9.2%
62,8840.0%0.01%
+20.0%
Q2 2022$1,240,072
-16.1%
62,8840.0%0.01%0.0%
Q1 2022$1,477,774
+35.4%
62,884
+57.0%
0.01%
+11.1%
Q4 2021$1,091,044
-1.1%
40,0530.0%0.01%
-10.0%
Q3 2021$1,103,060
+0.9%
40,053
+4.2%
0.01%0.0%
Q2 2021$1,093,632
-16.4%
38,4270.0%0.01%
-16.7%
Q1 2021$1,308,824
-6.0%
38,427
-8.1%
0.01%
-14.3%
Q4 2020$1,392,288
-3.3%
41,823
-6.6%
0.01%
-12.5%
Q3 2020$1,439,743
+16.7%
44,7960.0%0.02%
+14.3%
Q2 2020$1,233,682
+94.4%
44,796
+13.2%
0.01%
+55.6%
Q1 2020$634,532
-32.9%
39,5840.0%0.01%
-10.0%
Q4 2019$945,266
+35.4%
39,5840.0%0.01%
+25.0%
Q3 2019$698,262
-26.3%
39,584
+6.9%
0.01%
-27.3%
Q2 2019$947,608
-1.9%
37,016
+11.4%
0.01%0.0%
Q1 2019$966,083
+121.6%
33,2330.0%0.01%
+120.0%
Q4 2018$436,017
-35.1%
33,2330.0%0.01%
-28.6%
Q3 2018$671,971
-24.5%
33,233
-11.7%
0.01%
-36.4%
Q2 2018$890,000
+18.0%
37,652
+12.4%
0.01%
+22.2%
Q1 2018$754,000
-27.8%
33,4920.0%0.01%
-25.0%
Q4 2017$1,044,00033,4920.01%
Other shareholders
INSMED INC shareholders Q3 2020
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,799,225$40,519,00016.80%
Foresite Capital Management II, LLC 967,636$21,791,0007.25%
Palo Alto Investors LP 7,159,590$161,234,0006.90%
Asymmetry Capital Management, L.P. 162,185$3,652,0004.57%
NEXTHERA CAPITAL LP 918,523$20,685,0003.41%
Redmile Group, LLC 2,166,362$48,786,0001.88%
Orbimed Advisors 2,927,891$65,936,0000.82%
Rock Springs Capital Management LP 825,000$18,579,0000.79%
Bellevue Group AG 334,489$7,533,0000.75%
EMERALD ADVISERS, LLC 726,946$16,371,0000.66%
View complete list of INSMED INC shareholders